Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 6 | 2023 | 263 | 1.920 |
Why?
|
| Diagnostic Imaging | 4 | 2024 | 272 | 1.050 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2025 | 1659 | 0.960 |
Why?
|
| Hand | 1 | 2023 | 77 | 0.770 |
Why?
|
| Pneumonia, Viral | 2 | 2021 | 219 | 0.650 |
Why?
|
| Diverticulitis | 1 | 2020 | 38 | 0.630 |
Why?
|
| Students, Medical | 1 | 2020 | 265 | 0.530 |
Why?
|
| Thoracic Injuries | 1 | 2018 | 46 | 0.530 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 205 | 0.530 |
Why?
|
| Kidney Diseases | 1 | 2018 | 178 | 0.510 |
Why?
|
| Testicular Neoplasms | 1 | 2016 | 35 | 0.470 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 250 | 0.450 |
Why?
|
| Ultrasonography | 2 | 2018 | 491 | 0.440 |
Why?
|
| Radiography | 5 | 2023 | 558 | 0.420 |
Why?
|
| Internship and Residency | 1 | 2020 | 803 | 0.380 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1161 | 0.360 |
Why?
|
| Diagnosis, Differential | 5 | 2025 | 990 | 0.320 |
Why?
|
| Humans | 26 | 2026 | 65463 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2019 | 2250 | 0.260 |
Why?
|
| Artificial Intelligence | 2 | 2021 | 213 | 0.250 |
Why?
|
| Societies, Medical | 2 | 2025 | 400 | 0.230 |
Why?
|
| Abdominal Pain | 1 | 2025 | 99 | 0.220 |
Why?
|
| Computed Tomography Angiography | 1 | 2026 | 141 | 0.220 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2024 | 88 | 0.200 |
Why?
|
| Pulmonary Embolism | 1 | 2026 | 196 | 0.200 |
Why?
|
| Upper Extremity | 1 | 2023 | 57 | 0.190 |
Why?
|
| Acute Disease | 3 | 2019 | 663 | 0.180 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2022 | 10 | 0.180 |
Why?
|
| Motivation | 1 | 2023 | 298 | 0.170 |
Why?
|
| Utilization Review | 1 | 2020 | 32 | 0.160 |
Why?
|
| Fibrinolytic Agents | 1 | 2022 | 181 | 0.160 |
Why?
|
| Hernia, Abdominal | 1 | 2020 | 9 | 0.160 |
Why?
|
| Abdominal Wall | 1 | 2020 | 24 | 0.160 |
Why?
|
| Aorta, Abdominal | 2 | 2011 | 56 | 0.150 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 25 | 0.150 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 37 | 0.150 |
Why?
|
| Schools, Medical | 1 | 2020 | 150 | 0.150 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 98 | 0.150 |
Why?
|
| Osteomyelitis | 1 | 2019 | 24 | 0.150 |
Why?
|
| Foot | 1 | 2019 | 42 | 0.150 |
Why?
|
| Musculoskeletal Diseases | 1 | 2020 | 105 | 0.150 |
Why?
|
| Pandemics | 2 | 2021 | 682 | 0.140 |
Why?
|
| Coronary Artery Disease | 3 | 2009 | 326 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 180 | 0.140 |
Why?
|
| Biliary Tract | 1 | 2018 | 9 | 0.140 |
Why?
|
| Spine | 1 | 2018 | 55 | 0.130 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 54 | 0.130 |
Why?
|
| Multimodal Imaging | 1 | 2018 | 72 | 0.130 |
Why?
|
| Pancreas | 1 | 2018 | 153 | 0.130 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2018 | 116 | 0.130 |
Why?
|
| Pelvic Pain | 1 | 2016 | 20 | 0.120 |
Why?
|
| Fractures, Bone | 1 | 2018 | 138 | 0.120 |
Why?
|
| Abdomen, Acute | 1 | 2016 | 23 | 0.120 |
Why?
|
| Curriculum | 1 | 2020 | 610 | 0.120 |
Why?
|
| Contrast Media | 1 | 2018 | 432 | 0.120 |
Why?
|
| Radiologists | 3 | 2022 | 93 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2020 | 468 | 0.110 |
Why?
|
| United States | 3 | 2025 | 8148 | 0.110 |
Why?
|
| Massachusetts | 1 | 2020 | 2153 | 0.110 |
Why?
|
| Male | 8 | 2022 | 31187 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2022 | 6929 | 0.100 |
Why?
|
| Evidence-Based Medicine | 2 | 2025 | 464 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2776 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 389 | 0.090 |
Why?
|
| Child | 1 | 2020 | 4623 | 0.080 |
Why?
|
| Female | 8 | 2022 | 34193 | 0.080 |
Why?
|
| Aortic Diseases | 1 | 2011 | 65 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 186 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2011 | 162 | 0.070 |
Why?
|
| Pelvis | 2 | 2020 | 64 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 177 | 0.070 |
Why?
|
| CD40 Ligand | 1 | 2005 | 158 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2005 | 169 | 0.050 |
Why?
|
| Aging | 1 | 2011 | 774 | 0.050 |
Why?
|
| Texas | 3 | 2011 | 60 | 0.050 |
Why?
|
| Peer Review | 1 | 2022 | 26 | 0.040 |
Why?
|
| Hematoma | 1 | 2022 | 85 | 0.040 |
Why?
|
| Aged | 5 | 2022 | 15052 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2022 | 5644 | 0.040 |
Why?
|
| Predictive Value of Tests | 3 | 2011 | 1114 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 1564 | 0.040 |
Why?
|
| Hernia | 1 | 2020 | 14 | 0.040 |
Why?
|
| Adult | 5 | 2022 | 17461 | 0.040 |
Why?
|
| Workload | 1 | 2020 | 132 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2022 | 1143 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 308 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2018 | 50 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2022 | 732 | 0.030 |
Why?
|
| Middle Aged | 5 | 2019 | 18387 | 0.030 |
Why?
|
| Abdomen | 1 | 2016 | 97 | 0.030 |
Why?
|
| Sex Factors | 2 | 2011 | 995 | 0.030 |
Why?
|
| Risk Factors | 3 | 2011 | 5458 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 252 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 262 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 498 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 2390 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2009 | 33 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1592 | 0.020 |
Why?
|
| Platelet Activation | 1 | 2005 | 31 | 0.010 |
Why?
|
| Calcinosis | 1 | 2005 | 84 | 0.010 |
Why?
|
| Solubility | 1 | 2005 | 192 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2005 | 125 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 699 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 1710 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 2111 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 931 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 2721 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 2633 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 1451 | 0.010 |
Why?
|
| Biomarkers | 1 | 2005 | 1481 | 0.010 |
Why?
|